A clinical trial with TL-118 --a new treatment for metastatic pancreatic cancer--that has been ongoing at the Hadassah University Medical Center and three other oncology centers in Israel, has been expanded to the United States.
Dr. Itai Berger, Director of Hadassah’s Pediatric Neuro-Cognitive Center, and his team have created a model for early diagnosis and intervention with children who suffer from Attention Deficit Hyperactivity Disorder (ADHD) or Learning Disabilities (LD,) which is being piloted in the Jerusalem school system.
Dr. Ezekiel Landau, Director of the Pediatric Urology Department at the Hadassah University Medical Center, recently joined his surgical colleagues in the operating room at Cincinnati (Ohio) Children’s Hospital Medical Center as part of an ongoing collaboration between the two medical institutions.
Nehema Greniman Bauch, 30, a member of Hadassah International, was born and raised in Jerusalem, Israel.
While living and studying in Italy, she found herself “looking for a way to connect to the Jewish community and a friend told me about Young Hadassah International."
With an inaugural event, hosted by Hadassah International, Christie’s Fine Auction House, and the Israeli Embassy at the Moscow residence of HE Dorit Golender, Israel’s Ambassador to Russia, a multi-layered partnership between Russia and Hadassah was launched.
Karine Israel, the new head of Hadassah Paris, joined her mother, Michelle Israel, the former head of Hadassah Paris, in Jerusalem last week to celebrate Hadassah's 100-year anniversary.
The Hadassah University Medical Center, for the first time in Israel, has pioneered a new treatment for liver cancer, using a direct flow of high-voltage electric current to destroy a malignant tumor.
Clarise Dabah, of Mexico City, Mexico, joined with over 2,000 women and men from around the world to celebrate Hadassah’s Centennial anniversary in Jerusalem. The president of Hadassah Mexico “…was most excited to be here at Hadassah’s 100th anniversary; I have waited a year to be able to celebrate this momentous occasion.”
When Marjorie Mizrachi founded Hadassah Panama in 2006, the Sarah Wetsman Davidson Hospital Tower was still a dream. Last week the Mizrachi family stood inside that Tower and represented the Jewish community of Panama honoring the late Chief Rabbi Sion Levy and their own devoted family.
Enlivex – a Hadasit start-up company (under HBL) which develops a preventive immune-modulatory treatment invented by Prof. Dror Mevorach and his laboratory at Hadassah Medical Center - has successfully completed the first Phase I/IIa clinical trial for testing the safety and preliminary assessment of the effectiveness of ApoCell in the prevention and treatment of graft-versus-host disease (GVHD), a devastating and potentially life-threatening complication that occurs in 50-70% of patients receiving bone-marrow transplantation.